{"references": ["D. Paresh, et al., \"Safety assessment of a solid lipid curcumin particle preparation: Acute and subchronic toxicity studies,\" Food ChemToxicol., vol. 49, pp.1834-1842,Aug. 2011.", "R.A. Sharma,et al., \"Curcumin: the story so far,\" Eur. J. Cancer., vol.41, pp. 1955-1968, Aug. 2005.", "M.J. Ansari, S. Ahmadb, K. Kohli, J. Ali, and R.K. Khar, \"Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations,\" J. Pharmaceut. Biomed.vol.39, pp.132-138, Sep. 2005.", "Y.J. Wang,et al., \"Stability of curcumin in buffer solutions and characterization of its degradation products,\" J. Pharm. Biomed. Anal.vol.15, pp.1867-1876. 1997.", "Y. Kaminaga, et al., \"Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthusroseus,\" FEBS Letters. vol. 555, pp. 311-316, 2003.", "S. Clarysse, J. Brouwers, J. Tack, P. Annaert and P. Augustijns, \"Intestinal drug solubility estimation based on simulated intestinal fluids: Comparison with solubility in human intestinal fluids,\" Eur J PharmSci, vol.43, pp.260\u2013269, May. 2011.", "C.Saal and A.C. Petereit, \"Optimizing solubility: Kinetic versus thermodynamic solubility temptations and risks,\" Eur J PharmSci, vol.47, pp.589\u2013595, Aug. 2012.", "J.Brouwers, M.E.Brester, and P. Augustijns, \"Supersaturating Drug Delivery Systems: \tThe Answer to Solubility-Limited Oral bioavailability ?,\" J. Pharm. Sci., vol.98, no.8,pp.2549-72. Aug. 2009.", "P. A. Williams and G. O. Phillips, \"Introduction to food hydrocolloids. (In G. O. Phillips, & P. A. Williams (Eds.)),\" Handbook of hydrocolloids. New York, NY: CRC Press,2000. pp. 1\u201319\n[10]\tM. L. Fishman, H. K. Chau, P. H. Cooke and A. T. Hotchkiss, \"Global structure of microwave-assisted flash-extracted sugar beet pectin,\"J AgrFoodChem, 56(4), 1471e1478.W.-K. Chen, Linear Networks and Systems (Book style).\tBelmont, CA: Wadsworth, 1993, pp. 123\u2013135.\n[11]\tT. R. Laaman, \"Hydrocolloids: Fifteen practical tips. Hydrocolloids infood processing,\" Blackwell Publishing Ltd. and Institute of Food Technologists. 2011.\n[12]\tV. D. Prajapati, G. K. Jani, N. G. Moradiya and N. P. Randeria, \"Pharmaceutical applications of various natural gums, mucilages and their modified forms,\" CarbohydPolym., vol. 92, pp. 1685\u20131699, Nov. 2012.\n[13]\tH. Mirhosseini and B.T. Amid, \"A review study on chemical composition and molecular structure of newly plant gum exudates and seed gums,\" Food Res Int., vol. 46, pp. 387\u2013398, Nov. 2011.\n[14]\tE. Shoghi, E. Fuguet, E. Bosch and C. R\u00e0fols, \"Solubility\u2013pH profiles of some acidic, basic and amphoteric drugs,\" Eur J PharmSci, vol. 48, pp. 291\u2013300, 2013.\n[15]\tD. Eldera, and R. Holmb, \"Aqueous solubility: Simple predictive methods (in silico, in vitro and bio-relevant approaches),\"Int. J. Pharm., vol.453, pp. 3\u201311, Aug. 2013.\n[16]\tM. Vertzoni et al., \"Dissolution media simulating the intraluminal composition of \tthe small intestine: physiological issues and practical aspects,\" J. Pharm. Pharmacol. vol.56, pp. 453\u2013462, Apr. 2004.\n[17]\tJ. Bevernage, B. Hens, J. Brouwers, J. Tack, P. Annaert and P. Augustijns, \"Supersaturation in human gastric fluids,\" Eur. J. Pharm. Biopharm. vol. 81, pp. 184-189, May. 2012\n[18]\tE. Jantratid and J. Dressman, \"Biorelevant dissolution media simulating the proximal human gastrointestinal tract: an update,\" Dis. Tech., pp. 21-25, Aug. 2009.\n[19]\tJ. Bevernage, B. Hens, J. Brouwers, J. Tack, P. Annaertand P. Augustijns, \"Excipient-mediated supersaturation stabilization in human intestinal fluids,\" Mol. Pharmaceutics. vol. 8, pp.564-570, Apr. 2011.\n[20]\tN. Rodr\u00edguez-Hornedo, D. Murphy1, \"Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems,\" J. Pharm. Sci.vol.88, pp.651\u2013660, Nov. 1999.\n[21]\tJ.M. Miller, A. Beig, R.A. Carr, J.K. Spence and A. Dahan,\"A win\u2013win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability,\" Mol. Pharm. Vol.9, pp.2009\u20132016, Jun.2012.\n[22]\tZ.Q. Chen, Y. Liu, J.H. Zhao, L. Wang and N.P. Feng,\"Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system,\" Int J Nanomed, vol.7, pp.1115\u2013112,Feb. 2012."]}

Supersaturation of drugs in the gastrointestinal tract is one approach to increase the absorption of poorly water-soluble drugs. The stabilization of a supersaturated state was achieved by adding precipitation inhibitors that may act through a variety of mechanisms. In this study, the effect of the natural gums, acacia, gelatin, pectin and tragacanth on curcumin supersaturation in simulated gastric fluid (SGF) (pH 1.2), fasted state simulated gastric fluid (FaSSGF) (pH 1.6), and simulated intestinal fluid (SIF) (pH 6.8) was investigated. The results indicated that all natural gums significantly increased the curcumin solubility (about 1.2-6-fold) when compared to the absence of gum, and assisted in maintaining the supersaturated drug solution. Among the tested gums, pectin at 3% w/w was the best precipitation inhibitor with a significant increase in the degree of supersaturation about 3-fold in SGF, 2.4-fold in FaSSGF and 2-fold in SIF.